Charles S. Carter

4.2k citations

30 papers · 2.9k indexed · 1 hit paper · h-index 20

Immunology top 2%
Molecular Biology top 10%
Genetics top 2%
Oncology top 5%
Hematology top 2%

Co-authors: Susan F. Leitman Elizabeth J. Read Steven A. Rosenberg Stephen I. Katz Joost J. Oppenheim Daniel N. Sauder Harvey G. Klein Linda Muul
Topics: Immune Cell Function and Interaction (16 papers)Hematopoietic Stem Cell Transplantation (14 papers)Immunotherapy and Immune Responses (8 papers)
Cited by: Immunology Hematology Genetics
Journals: Science New England Journal of Medicine Nature Medicine
Partner nations: United States Malaysia South Africa

In The Last Decade

Charles S. Carter

30 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years

1995 983 citations R. Michael Blaese, Charles S. Carter et al. profile →

Peers

Countries citing papers authored by Charles S. Carter

Since Specialization

Citations

This map shows the geographic impact of Charles S. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Carter more than expected).

Fields of papers citing papers by Charles S. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Carter. The network helps show where Charles S. Carter may publish in the future.

Co-authorship network of co-authors of Charles S. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Carter. A scholar is included among the top collaborators of Charles S. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Carter. Charles S. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T Cell Depleted Peripheral Blood Stem Cell Allotransplantation with T Cell Add Back for Patients with Hematological Malignancies: Effect of Chronic GVHD on Outcome 2006 ·Biology of Blood and Marrow Transplantation ·Aldemar Montero,Bipin N. Savani,Aarthi Shenoy,Elizabeth J. Read,Charles S. Carter,Susan F. Leitman,Stephan Mielke,Katayoun Rezvani,Richard Childs,A. John Barrett	38
2	A functional comparison of mature human dendritic cells prepared in fluorinated ethylene‐propylene bags or polystyrene flasks 2006 ·Transfusion ·Roger Kurlander,Abdul Tawab,Yong Fan,Charles S. Carter,Elizabeth J. Read	19
3	Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method 2006 ·Transfusion ·Hanh Khuu,(unknown),Charles S. Carter,(unknown),Elizabeth J. Read	35
4	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,(unknown),Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	2
5	Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals 2005 ·Human Gene Therapy ·Richard A. Morgan,Robert Walker,Charles S. Carter,Ven Natarajan,Jorge A. Tavel,(unknown),(unknown),Linda Muul,Zhili Zheng,Shyla Jagannatha,Bruce A. Bunnell,Vicki Fellowes,Julia A. Metcalf,Randy Stevens,Michael Baseler,Susan F. Leitman,Elizabeth J. Read,R. Michael Blaese,H. Clifford Lane	55
6	Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells 2005 ·Nature Medicine ·Hua Zhang,Kevin Chua,Martin Guimond,Veena Kapoor,(unknown),Thomas A. Fleisher,Lauren Long,Donna Bernstein,Brenna J. Hill,Daniel C. Douek,Jay A. Berzofsky,Charles S. Carter,E.J. Read,Lee J. Helman,Crystal L. Mackall	310
7	Prospective evaluation of cell kinetics, yields and donor experiences during a single large‐volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells 2003 ·British Journal of Haematology ·Charles D. Bolan,Charles S. Carter,Robert Wesley,Yu Ying Yau,A. John Barrett,Richard Childs,Elizabeth J. Read,Susan F. Leitman	21
8	Optimized clinical-scale culture conditions for ex vivoselective depletion of host-reactive donor lymphocytes: astrategy for GVHD prophylaxis in allogeneic peripheral bloodstem cell transplantation 2002 ·Cytotherapy ·Scott R. Solomon,(unknown),Charles S. Carter,(unknown),(unknown),John Schindler,(unknown),(unknown),Jaroslav Michálek,(unknown),(unknown),Ellen S. Vitetta,A. John Barrett	1
9	Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study† 2002 ·Medical and Pediatric Oncology ·Ramzi Dagher,Lauren Long,Elizabeth J. Read,Susan F. Leitman,Charles S. Carter,Maria Tsokos,Theresa J. Goletz,Nilo A. Avila,Jay A. Berzofsky,Lee J. Helman,Crystal L. Mackall	118
10	Transplant dose of CD34⁺ and CD3⁺ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐back 2001 ·British Journal of Haematology ·Ryotaro Nakamura,Erkut Bahceci,Elizabeth J. Read,Susan F. Leitman,Charles S. Carter,Richard Childs,Cynthia E. Dunbar,Ronald E. Gress,Rosemary M. Altemus,Neal S. Young,A. John Barrett	53
11	Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell–Depleted Hematopoietic Allograft 2001 ·New England Journal of Medicine ·Mitchell E. Horwitz,A. John Barrett,Margaret R. Brown,Charles S. Carter,Richard Childs,John I. Gallin,Ronald E. Gress,Steven M. Holland,Gilda F. Linton,(unknown),Susan F. Leitman,Elizabeth J. Read,(unknown),Harry L. Malech	198
12	Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC) 1999 ·Human Gene Therapy ·Johnson M. Liu,Sonnie Kim,Elizabeth J. Read,Makoto Futaki,Inderjeet Dokal,Charles S. Carter,Susan F. Leitman,Michael Pensiero,Neal S. Young,Christopher Walsh	97
13	Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults 1998 ·Nature Medicine ·Robert Walker,Charles S. Carter,Linda Muul,Ven Natarajan,Betsey Herpin,Susan F. Leitman,Harvey G. Klein,Craig A. Mullen,Julia A. Metcalf,Michael Baseler,Judith Falloon,Richard T. Davey,Joseph A. Kovacs,Michael A. Polis,Henry Masur,R. Michael Blaese,H. Clifford Lane	99
14	IMPAIRED IMMUNE RECONSTITUTION POST SEQUENTIAL HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) INFUSION. † 962 1996 ·Pediatric Research ·(unknown),Crystal L. Mackall,Catherine V. Bare,Margaret R. Brown,Charles S. Carter,(unknown),Monica Yu,Thomas A. Fleisher,Susan F. Leitman,Gene M. Shearer,Leonard H. Wexler,Ronald E. Gress	1
15	Helper T Cells Infiltrating Human Renal Cell Carcinomas Have the Phenotype of Activated Memory-Like T Lymphocytes 1995 ·Journal of Immunotherapy ·Richard B. Alexander,Ellen Fitzgerald,Arnold Mixon,Charles S. Carter,(unknown),Peter A. Cohen,Steven A. Rosenberg	18
16	Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response 1994 ·Cancer ·Barbara A. Pockaj,Richard M. Sherry,John P. Wei,John R. Yannelli,Charles S. Carter,Susan F. Leitman,(unknown),Seth M. Steinberg,Steven A. Rosenberg,James Chih‐Hsin Yang	166
17	A Study of the Safety and Survival of the Adoptive Transfer of Genetically Marked Syngeneic Lymphocytes in HIV-infected Identical Twins 1993 ·Human Gene Therapy ·Robert Walker,(unknown),Charles S. Carter,Lauren A. Chang,Harvey G. Klein,H. Clifford Lane,(unknown),Craig A. Mullen	21
18	Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1β, or TNF-α production by human monocytes in vitro 1991 ·Clinical Immunology and Immunopathology ·Thomas Hoffman,Young Lim Lee,Elaine F. Lizzio,Anil Kumar Tripathi,John J. Jessop,(unknown),Tore G. Abrahamsen,Charles S. Carter,Joseph Puri	16
19	A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials 1988 ·Journal of Immunological Methods ·Paul Aebersold,Charles S. Carter,Cornelia Hyatt,(unknown),(unknown),(unknown),Steven A. Rosenberg	10
20	Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy 1987 ·Journal of Immunological Methods ·Linda Muul,Kathryn Nason-Burchenal,Charles S. Carter,(unknown),(unknown),Cornelia Hyatt,E P Director,Susan F. Leitman,Harvey G. Klein,Steven A. Rosenberg	47

About Charles S. Carter

Charles S. Carter is a scholar working on Hematology, Immunology and Virology, having authored 30 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Immunology (1.3k citations), Hematology (513 citations) and Genetics (1.1k citations). Charles S. Carter has collaborated with scholars based in United States, Malaysia and South Africa. Frequent co-authors include Susan F. Leitman, Elizabeth J. Read, Steven A. Rosenberg, Stephen I. Katz, Joost J. Oppenheim, Daniel N. Sauder, Harvey G. Klein, Linda Muul, R. Michael Blaese and Thomas A. Fleisher. Their work appears in journals such as Science, New England Journal of Medicine and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact